Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma

S Guan; B Liu; C Zhang; K-H Lee; S Sun; J Wei

doi:10.1007/s12094-013-1007-3

Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma

S Guan
, B Liu
, C Zhang
, K-H Lee
, S Sun
, J Wei

نتاج البحث: Article › مراجعة النظراء

24 اقتباسات (Scopus)

ملخص

The present study was undertaken to develop an in-house enzyme-linked immunosorbent assay (ELISA) using human leukocyte antigen class II restricted epitopes to test circulating autoantibodies to CD25 as a biomarker for esophageal cancer.

اللغة الأصلية	English
الصفحات (من إلى)	825-9
عدد الصفحات	5
دورية	Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
مستوى الصوت	15
رقم الإصدار	10
المعرِّفات الرقمية للأشياء	https://doi.org/10.1007/s12094-013-1007-3
حالة النشر	Published - أكتوبر 2013

أهداف الأمم المتحدة للتنمية المستدامة

يساهم هذا المخرج في تحقيق أهداف الأمم المتحدة للتنمية المستدامة التالية (SDGs)

Good health and well being

الوصول إلى المستند

10.1007/s12094-013-1007-3

قم بذكر هذا

Guan, S., Liu, B., Zhang, C., Lee, K.-H., Sun, S., & Wei, J. (2013). Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 15(10), 825-9. https://doi.org/10.1007/s12094-013-1007-3

Guan, S ; Liu, B ; Zhang, C وآخرون. / Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma. في: Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2013 ; المجلد 15, رقم 10. الصفحات 825-9.

@article{8a2ec6cde00b450a8d66528d80e9030d,

title = "Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma",

abstract = "The present study was undertaken to develop an in-house enzyme-linked immunosorbent assay (ELISA) using human leukocyte antigen class II restricted epitopes to test circulating autoantibodies to CD25 as a biomarker for esophageal cancer.",

author = "S Guan and B Liu and C Zhang and K-H Lee and S Sun and J Wei",

year = "2013",

month = oct,

doi = "10.1007/s12094-013-1007-3",

language = "English",

volume = "15",

pages = "825--9",

journal = "Clinical \& Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico",

issn = "1699-3055",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "10",

}

Guan, S, Liu, B, Zhang, C, Lee, K-H, Sun, S & Wei, J 2013, 'Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma', Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, المجلد 15, رقم 10, الصفحات 825-9. https://doi.org/10.1007/s12094-013-1007-3

Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma. / Guan, S; Liu, B; Zhang, C وآخرون.
في: Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, المجلد 15, رقم 10, ١٠.٢٠١٣, صفحة 825-9.

نتاج البحث: Article › مراجعة النظراء

TY - JOUR

T1 - Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma

AU - Guan, S

AU - Liu, B

AU - Zhang, C

AU - Lee, K-H

AU - Sun, S

AU - Wei, J

PY - 2013/10

Y1 - 2013/10

N2 - The present study was undertaken to develop an in-house enzyme-linked immunosorbent assay (ELISA) using human leukocyte antigen class II restricted epitopes to test circulating autoantibodies to CD25 as a biomarker for esophageal cancer.

AB - The present study was undertaken to develop an in-house enzyme-linked immunosorbent assay (ELISA) using human leukocyte antigen class II restricted epitopes to test circulating autoantibodies to CD25 as a biomarker for esophageal cancer.

U2 - 10.1007/s12094-013-1007-3

DO - 10.1007/s12094-013-1007-3

M3 - Article

C2 - 23423807

SN - 1699-3055

VL - 15

SP - 825

EP - 829

JO - Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

JF - Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

IS - 10

ER -

Guan S, Liu B, Zhang C, Lee KH, Sun S, Wei J. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2013 أكتوبر;15(10):825-9. doi: 10.1007/s12094-013-1007-3

Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma

ملخص

أهداف الأمم المتحدة للتنمية المستدامة

الوصول إلى المستند

بصمة

قم بذكر هذا